Introduction and aim Patients with colorectal cancer (CRC) may develop liver metastases. Surgical resection remains the best treatment of choice for colorectal liver metastases (CRLM) according to resectability criteria, with a long-term survival of 25% up to 41% after 5 years. Advanced age is associated with a higher incidence and co-morbidity, particularly cardiovascular disease, as well as deteriorating physiological reserves. The aim of this study was to analyse the overall and disease-free survival for patients with CRLM according to their chronological age. Methods Patients with CRLM were enrolled in the study. Data on gender, age, co-morbidity, metastasis characteristics (number, size and total metastatic volume (TMV)), use of perioperative chemotherapy and operative and post-operative complications were collected. Then, according to recent World Health Organization (WHO) guidelines, the patients were grouped by age. Statistical analysis was performed using the software R (ver. 2.14.1). Results Hepatic resection was performed in 149 patients (21 patients in the very elderly group, 79 in the elderly group and 49 in the younger group). The three groups were comparable in terms of operative duration, transfusion rate, length of high-dependency unit (HDU) stay and post-operative hospital stay. The very elderly group showed a non-significant increase in post-operative morbidity. The 30-day and 60-day/inpatient mortality rates increased with age without any significant statistically difference between the three groups (very elderly group 4.8% and 4.8%; elderly group: 2.5% and 3.8%; and younger group 0% and 2%). At 5 years, the overall survival was 28.6% for very elderly patients (≥75 years), 33.3% for elderly patients (≥65 to <75 years) and 43.5% for younger patients (≤65 years). The 1-, 3- and 5-year disease-free survival was similar across the groups. Conclusions Liver resection for CRLM in carefully selected patients above the age of 75 can be performed with acceptable morbidity and mortality rates, similar to those in younger patients. Moreover, the severity of CRLM in elderly patients is proven to be lesser than in younger patients. Thus, we can conclude that advanced chronological age cannot be considered a contraindication to hepatic resection for CRLM.

Liver resection for metastases from colorectal cancer in very elderly patients: New surgical horizons / Nardo, B.; Serafini, S.; Ruggiero, M.; Grande, R.; Fugetto, F.; Zullo, A.; Novello, M.; Rizzuto, A.; Bonaiuto, E.; Vaccarisi, S.; Cavallari, G.; Serra, R.; Cannistra, M.; Sacco, R.. - In: INTERNATIONAL JOURNAL OF SURGERY. - ISSN 1743-9191. - 33:(2016), pp. S135-S141. [10.1016/j.ijsu.2016.06.014]

Liver resection for metastases from colorectal cancer in very elderly patients: New surgical horizons

Grande R.;
2016

Abstract

Introduction and aim Patients with colorectal cancer (CRC) may develop liver metastases. Surgical resection remains the best treatment of choice for colorectal liver metastases (CRLM) according to resectability criteria, with a long-term survival of 25% up to 41% after 5 years. Advanced age is associated with a higher incidence and co-morbidity, particularly cardiovascular disease, as well as deteriorating physiological reserves. The aim of this study was to analyse the overall and disease-free survival for patients with CRLM according to their chronological age. Methods Patients with CRLM were enrolled in the study. Data on gender, age, co-morbidity, metastasis characteristics (number, size and total metastatic volume (TMV)), use of perioperative chemotherapy and operative and post-operative complications were collected. Then, according to recent World Health Organization (WHO) guidelines, the patients were grouped by age. Statistical analysis was performed using the software R (ver. 2.14.1). Results Hepatic resection was performed in 149 patients (21 patients in the very elderly group, 79 in the elderly group and 49 in the younger group). The three groups were comparable in terms of operative duration, transfusion rate, length of high-dependency unit (HDU) stay and post-operative hospital stay. The very elderly group showed a non-significant increase in post-operative morbidity. The 30-day and 60-day/inpatient mortality rates increased with age without any significant statistically difference between the three groups (very elderly group 4.8% and 4.8%; elderly group: 2.5% and 3.8%; and younger group 0% and 2%). At 5 years, the overall survival was 28.6% for very elderly patients (≥75 years), 33.3% for elderly patients (≥65 to <75 years) and 43.5% for younger patients (≤65 years). The 1-, 3- and 5-year disease-free survival was similar across the groups. Conclusions Liver resection for CRLM in carefully selected patients above the age of 75 can be performed with acceptable morbidity and mortality rates, similar to those in younger patients. Moreover, the severity of CRLM in elderly patients is proven to be lesser than in younger patients. Thus, we can conclude that advanced chronological age cannot be considered a contraindication to hepatic resection for CRLM.
2016
Colorectal metastases; Elderly; Liver resection; Prognostic factors; Survival; Age Factors; Aged; Aged, 80 and over; Colorectal Neoplasms; Disease-Free Survival; Female; Health Services for the Aged; Hepatectomy; Humans; Italy; Length of Stay; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Postoperative Complications; Retrospective Studies; Risk Factors; Treatment Outcome; Frail Elderly
01 Pubblicazione su rivista::01a Articolo in rivista
Liver resection for metastases from colorectal cancer in very elderly patients: New surgical horizons / Nardo, B.; Serafini, S.; Ruggiero, M.; Grande, R.; Fugetto, F.; Zullo, A.; Novello, M.; Rizzuto, A.; Bonaiuto, E.; Vaccarisi, S.; Cavallari, G.; Serra, R.; Cannistra, M.; Sacco, R.. - In: INTERNATIONAL JOURNAL OF SURGERY. - ISSN 1743-9191. - 33:(2016), pp. S135-S141. [10.1016/j.ijsu.2016.06.014]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1283061
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 22
social impact